My little company, Pointless, Inc., has been awarded some lucrative no-bid contracts in Iraq. This builds, of course, on our previous lucrative contract to implement corproate performance review systems at Abu Ghraib to demoralilze captive combatants – a controversial policy, we admit, but one that was needed to protect the lives of all of you.
Veolia Environnement SA is a large French company dealing with the water supply of many nations. They provide the technology for many water treatment and wastewater treatment facilities. They also provide energy services in Europe. They are the leading European heating systems operator in the housing, health, tertiary and industrial sectors, managing both heating and air-conditioning installations. Stock is available to US investors on the New York Stock Exchange under the ticker VE. This stock is a great way to diversify your portfolio. It has done well this year while many US stocks were plunging. Its outlooks are bright, dealing with key environmental areas and vital markets for much of the world. They are proven, profitable, and successful, with significant growth potential. And this foreign stock can help protect your investment when the US dollar weakens due to currency factors.
Here’s a good reason to shake well: the article “Shake Well Before Dispensing” by Dr. Kate Kelly (a pharmacist). This article points out that liquid medicines that require shaking may not have been properly shaken by the pharmacist before putting into your bottle, resulting in possible large variations in the actual dose you receive. Be diligent and make sure your pharmacist SHAKES WELL BEFORE SERVING you your bottle of medicine. And then continue to shake well every time before dispensing the medication.
Silver was knocked down to below $11 an ounce recently, apparently dragged down by falling oil and efforts to strengthen the dollar (alleged by some to be pre-election manipulation to keep voters happy). But the fundamentals of silver point to a much higher price potential. Global silver inventories are down. Millions more ounces of silver are being consumed industrially than are being produced, and production of silver from mines is difficult to increase – partly because silver tends to be a byproduct from mining of other metals, and if their demand does not increase dramatically, there is little motivation to ramp up silver production.
A huge reason to expect silver to rocket upward in the near future is the emergence of new hedge funds devoted to silver. Barclays of England brought the SLV exchange traded fund online this year for American investors, and now more such funds are planned for Europe, Australia, and New Zealand. Investment demand for silver can be expected to escalate as it finally becomes easy to invest in, and as people recognize it as protection against inflation. But the key dynamic is that silver is rare, being used up steadily for industrial needs. In fact, it is rarer than gold in terms of available physical silver above ground. But it’s an a ridiculously low level of around 1/60th the price of gold, when historically it’s been at 1/16 or higher – a logical price given the relative amounts present in the earth’s crust.
What all this means is that today, this month, perhaps this year, you have a marvelous window of opportunity to invest in silver. Get the real physical metal, get some SLV exchange traded fund in your 401(k), and get some silver stocks such as Sliver Wheaton (SLW) or Silver Standard Resources (SSRI). If you want a speculative junior mining company (for advanced traders only), try Clifton Mining (CFTN.pk) or Sterling Minerals (srlm.ob).
Celgene, one of the best biotech/pharma companies out there, has an incredible business model, amazing drugs, and a very hot pipeline. I recommend it as a key part of your investment portfolio. One reason is that Celgene is developing a whole class of new but related drugs called IMIDS, building on the success of thalidomide and Revlimid in dealing with certain cancers and other diseases. Its price has been held back this summer and is ready to move forward at this excellent buying opportunity.
As reported by the Multiple Myeloma Research Foundation:
Like thalidomide, IMiDs are immunomodulatory agents (drugs that can modify or regulate the functioning of the immune system). IMiDs appear to have multiple actions, including both anticancer and anti-inflammatory activities.
Details on IMiDs’ Mechanism of Action
IMiDs affect the immune system in several ways. They induce immune responses, enhance activity of immune cells, and inhibit inflammation. IMiDs appear to alter the levels of various cytokines (growth factors or factors that inhibit growth) and affect cells of the immune system. Studies show that IMiDs:
- Enhance the activation of T cells
- Enhance the activity of natural killer cells, which help kill cancer cells
- Enhance production of interleukin 2 (IL-2), a growth factor for T cells
- Inhibit inflammatory cytokines including
- Tumor necrosis factor-alpha (TNF-α)
- Interleukin 1-beta (IL-1β)
- Stimulate the production of interleukin 10 (IL-10), an anti-inflammatory cytokine
In addition, the IMiDs inhibit the growth of new blood vessels (angiogenesis) through inhibition of vascular endothelial growth factor (VEGF).
Celgene has been down a little in the past few weeks, and frankly seems coiled and ready to spring. Watch for a strong move this week or early next week. By the end of the year, I would not be suprised to see it 30% higher than it is now.
Microsoft has admitted to another critical flaw being exploited in “zero day” attacks in all versions of Microsoft Office programs, across all platforms, apparently even more serious than other recently announced critical flaws. The newly found Darn.Me/Curse.Me backdoor trojan program, first spotted causing havoc on Whitehouse computers, allows hackers to take over computers who open documents of any kind, from any source. The program is unusually malicious, typically allowing malicious hackers to steal the identity of users or, in several documented cases, their very soul. The souls of two victims are reportedly suffering eternal damnation already after accidentally opening a document infected with the Curse.Me variant of the trojan. The White House is not acknowledging who the affected parties are, but Federal security experts note that the infection has been reported among members of Congress, the Supreme Court, the Pentagon, and the New York Times, and may spread around the globe shortly. Technical support crews have been unable to retrieve the contents of the injected souls.
Microsoft does not have a patch for this vulnerability, and does not have plans in place to provide one, though an improved and more expensive version of Office will be announced soon that can be trusted “for sure this time,” according to a Microsoft spokesman who refused to take the bag off his head during the press conference. “For the present time,” he said, “we encourage users to avoid use of our software. Rather than risk loss of your identity or even your soul by using Word, Outlook, Internet Explorer, or any of our other leading products, it might be wise to take up bowling for the present time. Maybe some reruns on television. Reading is good, too.”
Free Proofreading of Business Cards: One Easy Way to Help Your Immigrant Friends in 10 Seconds or Less
While I got a chuckle from the message of this business card that I picked up at an oriental grocery store recently, it made me realize that native English speakers could do a great service to their immigrant friends and acquaintances by simply offering to proofread materials that they might wish to print for their business. Ten seconds of proofreading would have made this business card more effective.
When it comes to offering help to our friends and neighbors with English as a second language, it’s time for more of us to step up and say, “We delivery!” Or words to that effect.
A valuable and no-nonsense source of analysis on the economy is JS Mineset. Author Jim Sinclair’s commentary on inflation, debt, finances, mortgages, investing, and especially precious metals offers a savvy look at what most investors are gleefully ignoring. Most recently, he has exposed the foolishness of the media/government/Wall Street spin about the “Goldilocks economy.” What we are facing is much more painful and serious than the spin-masters would have us believe, but there are things you can do – or must do! – now to prepare yourself. Buying more stocks like Ford and General Motors is not the answer.